This new acquisition significantly strengthens Cicor's engineering capabilities in the Medtech sector, and creates one of the strongest R&D platforms in the European EMS industry.

CMS Corporate Partner, Horea Popescu, commented: “The successful completion of this transaction marks a significant milestone in Cicor's journey, reinforcing its position as a key player in the European EMS industry. We are pleased to have supported our client, leveraging our wide-ranging expertise in transactions of this nature. We are confident that this strategic alliance will open new avenues for innovation and growth."

Elena Andrei, Senior Associate in the Corporate & M&A practice at CMS, added: “It has been a pleasure to play a key role on this deal, which has helped to solidify Cicor's strong position in the Medtech sector. We look forward to witnessing Cicor's continued growth.”

The CMS team was led by Elena Andrei (Corporate & M&A) and Horea Popescu (Corporate & M&A). The wider team included Rares Crismaru, Simona Strava, Rebeca Vladislav (Corporate & M&A); Claudia Nagy, Oana Chivu (Competition); Laura Grigore (Regulatory); Carmen Turcu (Intellectual Property); and Andrei Tercu (Tax). Support was also provided by CMS Germany, led by Maxine Notstain and Dr. Hendrik Hirsch (Corporate & M&A).